Author | Primary study goal | Study population | Presenting PROMs data | Visualization | Outcomes of included studies | |||
---|---|---|---|---|---|---|---|---|
Type of PROMs | What is being presented? | Graphic visualisation format | Comparator | Preferences | Interpretation accuracy | |||
Individual level PROMs data visualization, clinicians | ||||||||
Brundage [16] | To investigate the interpretability of current PRO data presentation formats | N = 50 patients with variety of cancer diagnoses; N = 20 clinicians in active practice, from Johns Hopkins Clinical Research Network (JHCRN)* | EORTC-QLQ-C30 scores | Individual scores and group means | Two line graphs: | Previous scores | Preference for line graphs: overall ease-of-understanding and usefulness | Interpretation accuracy was high across formats |
Higher = better functioning | 90% of clinicians preferred formats displaying multiple time-points vs single time-points | Inconsistency between whether higher scores were better or worse contributes to incorrect accuracy (Uptrend lines intuitively signify improvement of understanding) | ||||||
Higher = more symptoms | Tabulated scores were considered boring but straightforward | |||||||
Bubble plot | ||||||||
Heat maps | ||||||||
Brundage [37] | To evaluate the interpretation accuracy and perceived clarity of various strategies for displaying clinical trial PRO findings | Oncology clinicians (N = 233) and PRO researchers (N = 248), from JHCRN* | PRO results from hypothetical clinical trial (cross-sectional, longitudinal) | Longitudinal individual data, proportions | Bar chart | Line graph also normed against general population | Not one approach for either longitudinal data or proportions changed is universally appealing, nor is free of misinterpretation errors | Line graph: |
Pie chart | More likely to be interpreted correctly “better” vs “normed” graphs (p = 0.04) | |||||||
3 Line graphs: | No differences between “better” and “more” | |||||||
1) Higher = “better” functioning; | Regardless of graph type and version, adding asterisks for clinical significance and confidence limits did not contribute to better interpretation accuracy | |||||||
2) Higher = “more” symptoms; | Bar chart/pie chart: | |||||||
3) “Normed” against general population | Respondents less likely to make interpretation errors with pie vs bar charts (p < 0.001) | |||||||
Odds of selecting an “incorrect” treatment significantly lower in pie charts compared to bar charts | ||||||||
Clarity ratings did not differ between formats | ||||||||
Damman [14] | To investigate: | Interviews: patients with Parkinson's disease (N = 13) and clinicians (N = 14) | Not specified | Individual scores | Line graph | Patients with the same age, gender and disease duration | Strong preference for individual PROMs data over time | Individual PROMs scores with comparative data of similar patients were found useful, some expressed doubts |
(a) How patients and clinicians think about using PROMs during consultations; | Survey: patients (N = 115), the Netherlands | Bar graph | Line and bar graphs | |||||
(b) For which purpose patients and clinicians use PROMs during consultations; | Line graph with comparative data over time (i.e. average scores of similar patients) | Scores from repeated measurements over time | ||||||
(c) How patients interpret PROMs information presented in various formats | Multiple individual quality of life, rather than one overall quality of life score | |||||||
Identified the possibility to use aggregated PROMs scores as evidence for treatment options | ||||||||
Grossman [27] | To identify the design requirements for an interface that assists patients with PRO survey completion and interpretation; to build and evaluate the interface of PROMs feedback | Interview: N = 13 patients with heart failure and N = 11 clinicians, study location or country was not described | Health IT Usability Evaluation Scale (Health-ITUES) | Individual scores | Small cards: Contains a short sentence to describe a severe symptom, which when clicked on provides textual educational information | N/A | Perceiving the mockup as useful and easy-to-use | Two providers reported that PROs might reduce their cognitive load |
Usability testing: N = 12 patients with heart failure | Graph: | Preference for tracking symptoms over time | ||||||
Bar chart that lists the patient’s symptoms from most to least severe and displays each symptom’s severity score | ||||||||
Large cards: | ||||||||
Displays a symptom name, its two-sentence description, a visual representation of its severity, and a link to textual educational information | ||||||||
Hartzler [36] | To share lessons learned from engaging clinicians to inform design of visual dashboards | Clinicians: N = 12 for interviews, N = 40 for surveys and consensus meeting, N = 9 for user testing, study location or country was not described | Not specified | Individual scores | PRO data needs appear to differ for health care providers and administrative staff as key target users | N/A | Participants liked viewing trends over time | Value was found in developing meaningful ways to report on this new source of data |
The functional prototype has 3 components: | Participants found the views to provide a useful basis for comparison | In addition to the information buttons provided on “how to interpret this chart,” clear labels are needed, such as on chart axes | ||||||
(1) An “At a glance” screen providing a simple data overview of PROs data | ||||||||
(2) An “Analyze” screen providing a data view the user can filter | ||||||||
(3) A “Data quality” screen | ||||||||
Hartzler [6] | To conduct a HCD to engage patients, providers, and interaction design experts in the development of visual “PRO dashboards” that illustrate personalized trends in patients’ HRQoL following prostate cancer treatment | Focus groups (N = 60 patients) | Not specified | Individual scores | Pictographs | The dashboard compares patients’ trends with trends from “men like you” matched by default by age and treatment derived from a previously published prostate cancer cohort | Pictographs less helpful than bar charts, line graphs, or tables (P < .001) | Pictographs might reach patients with limited literacy |
N = 50 prostate cancer patients and N = 50 clinicians, study location or country was not described | Bar charts | Preferred bar charts and line graphs | Some participants, both patients and providers, expressed concern over inclusion of comparison scores without representation of data variability (e.g., confidence intervals, error bars), while others preferred simpler charts and graphs | |||||
Line graphs | ||||||||
Izard [3] | To develop graphic dashboards of questionnaire responses from patients with prostate cancer to facilitate clinical integration of HRQoL measurement | N = 50 prostate cancer patients and N = 50 providers from Seattle, USA | Expanded Prostate Cancer Index | Individual scores | Bar chart | Previous scores; ‘patients like me’ | No universally preferred dashboard format: 30% preferred tables, 34% preferred bar charts, and 34% preferred line graphs | Helpfulness and confidence ratings varied among dashboard format. Pictographs had the lowest helpfulness compared with table, bar, and line graph formats |
Line graph | ||||||||
Table that display HRQOL data in raw form | ||||||||
Facial expression pictograph | ||||||||
Jagsi [35] | To investigate practicing oncologists view on incorporating routine collection of PROs into cancer care | N = 17 oncologists, USA | Edmonton Symptom Assessment System | Individual scores | Bar chart | Previous scores | Ability to track symptoms over time and effect of intervention | Keep it simple: limit number of symptoms |
Link number scale to narrative | ||||||||
Kuijpers [4] | To investigate patients’ and clinicians’ understanding of and preferences for different graphical presentation styles for individual-level EORTC QLQC30 scores | N = 548 cancer patients in four European countries and N = 227 clinicians, the Netherlands | EORTC QLQ-C30 | Individual scores | Bar chart with color | The preferred comparison group was one’s own previous results (40.9%) | Medical specialist: | Medical specialist: |
Bar chart without color | Heat map (46%) | Objective understanding of 78% | ||||||
Line graph with color | Nurses: | Nurses: | ||||||
Line graph without color | Bar chart (non-colored) and heat map (32%) | Objective understanding of 74% | ||||||
Heat map | 85% of all HCP’s indicated that the graphs were (easy) to understand, not differing between professions or graphical presentation styles | |||||||
Uniformity in scoring direction would be preferred | ||||||||
A significant difference for overall change scores, with the non-colored bar charts being interpreted correctly more often than the other graphical displays | ||||||||
Ragouzeos [25] | To develop a “dashboard” for RA patients to display relevant PRO measures for discussion during a routine RA clinical visit | Patients with rheumatology (N = 45) and providers (N = 12), USA | Not specified | Individual scores | Prototype PRO dashboard (on paper) | Previous scores | N/A | Information needs to be clearly focused on what is most essential |
Important to show progress over time | ||||||||
Santana [33] | To describe the process, feasibility and acceptability of use of the Health Utilities Index (HUI) in routine clinical care | Pre- and post-heart and -lung transplant patients (N = 151), Canada | Health Utilities Index (HUI) | Individual scores | HUI score card, using a color-coded system | Pre- and post-treatment scores | N/A | Clinicians did not need much time to understand the use of the HUI score card |
Clinicians developed their own way of using the information over time | ||||||||
Smith [18] | To improve formats for presenting individual-level PRO data (for patient monitoring) and group-level PRO data (for reporting comparative clinical studies) | N = 40 clinicians in active practice and N = 39 patients diagnosed with cancer ≥ 6 months previously, not currently receiving chemotherapy/radiation or within 6 months of surgery, from JHCRN* | Not specified | Individual scores, proportional data | Line graphs | Previous scores | 75% preferred the line graph | Ease-of-understanding ratings were high for all formats |
Pie charts | Directional inconsistency emerged as an interpretation challenge | |||||||
Bar charts | Format interpretation challenges included explaining the meaning of scores (i.e., whether scores are good/bad, what normal is) | |||||||
Icon array | ||||||||
Snyder [34] | To test approaches for presenting PRO data to improve interpretability | N = 627 cancer patients/survivors, N = 236 oncology clinicians, and N = 250 PRO researchers for survey, from JHCRN* | Not specified | Individual scores | 3 line-graphs: | Previous scores | N/A | The proportion responding correctly across the 4 directionality items ranged from 80 to 100% |
N = 10 patients and N = 10 clinicians for interviews | 1) Green-shaded normal range | Red circles were interpreted more accurately than green shading | ||||||
2) Red-circled possibly concerning scores | Higher = better were interpreted more accurately versus higher = more | |||||||
3) Red threshold-lines between normal and concerning scores | Threshold-line significantly more likely to be rated “very” clear and most useful compared with green shading and red circles | |||||||
Group level/aggregated PROMs data visualization, clinicians | ||||||||
Brundage [16] | To investigate the interpretability of current PRO data presentation formats | N = 50 patients with variety of cancer diagnoses; N = 20 clinicians in active practice, from JHCRN* | EORTC-QLQ-C30 scores | Individual scores and group means | Line graph means over time | Two treatments (study arms) | 90% of clinicians preferred formats displaying multiple time-points | Line graphs contributed to overall ease-of-understanding and usefulness |
Line graph with norms | Preference for line graphs of normed sores or with confidence intervals | Normed scores provided basis for comparison beyond two treatments, p-values and confidence intervals were particularly important for publications | ||||||
Line graph with confidence intervals | Some preference for bar charts to compare treatments | Cumulative distributing function confusing and difficult to interpret | ||||||
Bar chart of average changes | Inconsistency between whether higher scores were better or worse contributes to incorrect accuracy | |||||||
Bar chart with definition (improved, stable, worsened) | ||||||||
•Cumulative distribution functions | ||||||||
Damman [14] | To investigate: | Interviews: patients with Parkinson's disease (N = 13) and clinicians (N = 14) | Not specified | Individual scores | Line graph with results of 2 treatment options | Patients with the same age, gender and disease duration | Identified the possibility to use aggregated PROMs scores as evidence for treatment options | N/A |
(a) How patients and clinicians think about using PROMs during consultations; | Survey: patients (N = 115), the Netherlands | Bar chart with results of 2 treatment options | Aggregated PROMs scores for provider options could be useful, but would not be used much in clinical practice | |||||
(b) For which purpose patients and clinicians use PROMs during consultations; | Bar chart with performance of 2 providers | |||||||
(c) How patients interpret PROMs information presented in various formats | ||||||||
Liu [28] | To develop Rheumatoid Arthritis (RA) ‘dashboard’ that could facilitate conversations about PROs and is acceptable to a wide range of patients, including English and Spanish speakers, with adequate or limited health literacy | N = 25 RA patients and N = 11 clinicians from two academic rheumatology clinics, California (USA) | (1) Clinical Disease Activity Index (CDAI) | Individual scores | Line graph | Aggregated clinical data | A dashboard is a potential method for aggregating data from various sources | A ‘snapshot’ of relevant information for a particular patient would make HCP’s own medical decisions easier |
(2) Patient-Reported Outcomes Measurement Information System (PROMIS)-physical function scale | Clinicians were very interested in customizing the dashboard to their own needs and recommended that it can be designed to present information that is more detailed | |||||||
(3) Pain score | ||||||||
Smith [18] | To improve formats for presenting individual-level PRO data (for patient monitoring) and group-level PRO data (for reporting comparative clinical studies) | N = 40 clinicians in active practice and N = 39 patients diagnosed with cancer ≥ 6 months previously, not currently receiving chemotherapy/radiation or within 6 months of surgery, from JHCRN* | Not specified | Individual scores, proportional data | Line graphs | Average changes | For proportional data formats: pie charts (70%) | Median ease-of-understanding ranged from 6.5 to 8 |
Pie charts | Few clinicians (10%) preferred bar charts | Mixed feelings about indications of clinical significance in terms of having p-values in addition to confidence intervals and asterisks indicating important differences | ||||||
Bar charts | 75% preferred the line graph | Directional inconsistency emerged as an interpretation challenge | ||||||
Icon array | Format interpretation challenges included explaining the meaning of scores (i.e., whether scores are good/bad, what normal is) | |||||||
Tolbert [29] | To identify the association of PRO score directionality and score norming on a) how accurately PRO scores are interpreted and b) how clearly they are rated by patients, clinicians, and PRO researchers | N = 629 patients (various oncologic diagnoses), N = 139 oncology clinicians, and N = 249 PRO researchers, conducted at the Johns Hopkins Clinical Research Network (JHCRN)* | Two treatments | Mean scores | Line graph 3 versions: | Two treatments | “Better” formatted line graphs were rated most often as “very clear” or “somewhat clear” by all three groups (84% by patients, 81% by clinicians, and 85% by researchers) | Answers correct for “better”: 70%; “more”: 65%; “normed”: 65% |
(1) Lines going up indicating “better” outcomes | However, the range in the proportion rating each format “very clear” or “somewhat clear” was narrow: 77% to 85% | “More” line graph comments noted that up could mean different things, which could lead to errors | ||||||
(2) Lines going up indicating “more” (better for function domains, worse for symptoms). 3) Lines “normed” to a general population average of 50 | “Better” line graph comments pointed out how changing the scale could result in interpretation errors as one must orient to the direction of the scale each time | |||||||
Tolbert [20] | To identify best practices for presenting PRO results expressed as proportions of patients with changes from baseline (improved/ stable/ worsened) for use in patient educational materials and decision aids | N = 629 patients (various oncologic diagnoses, treated), N = 139 oncology clinicians, and N = 249 PRO researchers, conducted at the Johns Hopkins Clinical Research Network (JHCRN)* | Two treatments | Proportions changed | Pie chart | Two treatments | Preferred pie charts: these were easy to read and enabled obtaining information quickly | Clinician and researchers scored pie charts as the most accurately interpreted |
Bar chart | 43% had positive feedback on icon arrays | In general, bar graphs were less accurately interpreted than pie charts and icon arrays | ||||||
Icon array | 38% had positive feedback on bar charts | Noted helpful aspects of bar charts: “Side | ||||||
by side comparisons are much easier to read and comprehend” | ||||||||
van Overveld [19] | To investigate the preferences of receiving feedback between stakeholders | N = 37 patients, medical specialists, allied health professionals and health insurers in the Netherlands | Audit data on professional practice and health care outcomes | National average scores | Bar graph | National average scores | Preference for bar charts since they are easier to read | Box plots, Kaplan–Meier graphs and funnel plots give a less clear overview and are more difficult to interpret |
Pie chart | For survival and process indicators: Kaplan–Meier graphs and box plots | Find a balance between giving feedback and giving too much information | ||||||
Line graph | Give an overview of the results first, followed by the details | |||||||
Point graph | Present it that one can easily understand without explanation | |||||||
Area graph | ||||||||
Box plot | ||||||||
Kaplan- Meier graph | ||||||||
Funnel plot |